We find that patients with CTCL are at increased risk of second malignancies, especially Hodgkin and non-Hodgkin lymphoma, lung cancer, bladder cancer...
The prevalence of lymphoma reported in sarcoidosis patients is higher than the general population which further supports the possible increased risk...
Prevalence of neuromuscular, musculoskeletal, visceral, oncologic, and other late effects contributing to functional impairment and disability in HL...